Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Philipps University Marburg | OTHER |
| German Research Foundation | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Cognitive behavior therapy is the most effective treatment of obsessive-compulsive disorder. However, the majority of treated patients remain symptomatic. The metacognitive therapy by Wells (1997) could achieve substantial gains in first pilot studies. The purpose of this study is to investigate this approach with a randomized controlled trial by comparing metacognitive therapy with exposure and response prevention for obsessive-compulsive disorder.
The purpose of this study is to investigate metacognitive therapy by Wells (1997) with a randomized controlled trial by comparing metacognitive therapy with exposure and response prevention for obsessive-compulsive disorder.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Metacognitive Therapy | Experimental | Metacognitive Therapy for OCD according to Wells (1997) |
|
| Exposure and Response Prevention | Experimental | Exposure and Response Prevention for OCD according to Kozak & Foa (1997) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Metacognitive Therapy | Behavioral | Metacognitive Therapy for OCD according to Wells (1997) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in Symptom Severity (Yale Brown Obsessive-Compulsive Scale; Y-BOCS) | Change in Symptom Severity (Yale Brown Obsessive-Compulsive Scale; Y-BOCS) | at pretest (admission), after completion of 6 therapeutic sessions (after an expected average of 6 weeks), at posttest after completion of 12 therapeutic sessions (after an expected average of 12 weeks), at follow-up (6 months after end of treatment) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Symptom Severity (Padua Inventory; PI) | Change in Symptom Severity (Padua Inventory; PI) | at pretest (admission), after completion of 6 therapeutic sessions (after an expected average of 6 weeks), at posttest after completion of 12 therapeutic sessions (after an expected average of 12 weeks), at follow-up (6 months after end of treatment) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Cornelia Exner, Prof. Dr. | Leipzig University | Principal Investigator |
| Julia A. Glombiewski, Dr. | Philipps University Marburg | Principal Investigator |
| Alexandra Kleiman, Dr. | Leipzig University | Study Director |
| Anke Haberkamp, Dr. | Philipps University Marburg | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Leipzig University | Leipzig | Germany | ||||
| Philipps University Marburg |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009771 | Obsessive-Compulsive Disorder |
| ID | Term |
|---|---|
| D001008 | Anxiety Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Exposure and Response Prevention | Behavioral | Exposure and Response Prevention for OCD according to Kozak & Foa (1997) |
|
| Change in general psychopathology (Symptom Checklist-90-Revised, SCL-90-R) | Change in general psychopathology (Symptom Checklist-90-Revised, SCL-90-R) | at pretest (admission), after completion of 6 therapeutic sessions (after an expected average of 6 weeks), at posttest after completion of 12 therapeutic sessions (after an expected average of 12 weeks), at follow-up (6 months after end of treatment) |
| Change in Metacognitions (Metacognitions Questionnaire, short version, MCQ-30) | Change in Metacognitions (Metacognitions Questionnaire, short version, MCQ-30) | at pretest (admission), after completion of 6 therapeutic sessions (after an expected average of 6 weeks), at posttest after completion of 12 therapeutic sessions (after an expected average of 12 weeks), at follow-up (6 months after end of treatment) |
| Change in Obsessive Beliefs (Obsessive Beliefs Questionnaire, OBQ) | Change in Obsessive Beliefs (Obsessive Beliefs Questionnaire, OBQ) | at pretest (admission), after completion of 6 therapeutic sessions (after an expected average of 6 weeks), at posttest after completion of 12 therapeutic sessions (after an expected average of 12 weeks), at follow-up (6 months after end of treatment) |
| Change in Behavioral Avoidance (Behavioral Avoidance Test, BAT) | Change in Behavioral Avoidance (Behavioral Avoidance Test, BAT) | at pretest (admission), after completion of 6 therapeutic sessions (after an expected average of 6 weeks), at posttest after completion of 12 therapeutic sessions (after an expected average of 12 weeks), at follow-up (6 months after end of treatment) |
| Change in Depression (Beck Depression Inventory, BDI-II) | Change in Depression (Beck Depression Inventory, BDI-II) | at pretest (admission), after completion of 6 therapeutic sessions (after an expected average of 6 weeks), at posttest after completion of 12 therapeutic sessions (after an expected average of 12 weeks), at follow-up (6 months after end of treatment) |
| Change in Anxiety (Beck Anxiety Inventory, BAI) | Change in Anxiety (Beck Anxiety Inventory, BAI) | at pretest (admission), after completion of 6 therapeutic sessions (after an expected average of 6 weeks), at posttest after completion of 12 therapeutic sessions (after an expected average of 12 weeks), at follow-up (6 months after end of treatment) |
| Change in Symptom Severity (Clinical Global Impressions; CGI) | Change in Symptom Severity (Clinical Global Impressions; CGI) | at pretest (admission), after completion of 6 therapeutic sessions (after an expected average of 6 weeks), at posttest after completion of 12 therapeutic sessions (after an expected average of 12 weeks), at follow-up (6 months after end of treatment) |
| Change in psychosocial functioning (Global Assessment of Functioning Scale, GAF) | Change in psychosocial functioning (Global Assessment of Functioning Scale, GAF) | at pretest (admission), after completion of 6 therapeutic sessions (after an expected average of 6 weeks), at posttest after completion of 12 therapeutic sessions (after an expected average of 12 weeks), at follow-up (6 months after end of treatment) |
| Change in quality of life (The World Health Organization Quality of Life, WHOQOL_BREF) | Change in quality of life (The World Health Organization Quality of Life, WHOQOL_BREF) | at pretest (admission), after completion of 6 therapeutic sessions (after an expected average of 6 weeks), at posttest after completion of 12 therapeutic sessions (after an expected average of 12 weeks), at follow-up (6 months after end of treatment) |
| Difference in efficiency (length of treatment) | documentation of number of sessions | immediately after completion of therapy (after an expected avarage of 12 weeks) |
| Difference in medical costs (based on the length of treatment) | Difference in medical costs (based on the length of treatment) | immediately after completion of therapy (after an expected avarage of 12 weeks) |
| Difference in negative effects of psychotherapy (Inventory for the Assessment of Negative Effects of Psychotherapy, INEP) | Difference in negative effects of psychotherapy (Inventory for the Assessment of Negative Effects of Psychotherapy, INEP) | after completion of 6 therapeutic sessions (after an expected avarage of 6 weeks), at posttest after completion of 12 therapeutic sessions (after an expected avarage of 12 weeks), at follow-up (6 months after end of treatment) |
| Difference in satisfaction with the treatment | Difference in satisfaction with the treatment | immediately after completion of therapy (after an expected avarage of 12 weeks) |
| Marburg |
| Germany |